AbbVie’s Qulipta cleared for migraine prevention, setting up Biohaven clashAbbVie has added a third drug to its arsenal in the crowded migraine market, getting FDA approval for Share XAbbVie’s Qulipta cleared for migraine prevention, setting up Biohaven clashhttps://pharmaphorum.com/news/abbvies-qulipta-cleared-for-migraine-prevention-setting-up-biohaven-clash/
